Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hudson River Capital Holdings is a private investment and advisory firm and the family office of the Pickett family, led by Dan Pickett. The firm focuses on growth-stage private investments and intellectual property-driven opportunities rather than operating as a drug developer, biotechnology company, or healthcare services provider. Its portfolio spans multiple sectors including technology, infrastructure, media, logistics, and selected healthcare-related investments. Hudson River Capital Holdings works closely with portfolio companies through active strategic involvement and board participation. Based on the available evidence, it should be classified as a financial sponsor/investment vehicle, not a life sciences or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hudson River Capital Holdings.